These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 31985523)

  • 1. Restarting Oral Anticoagulation in Patients With Atrial Fibrillation After an Intracranial Hemorrhage.
    Nguyen NY; Frishman WH
    Cardiol Rev; 2020; 28(4):190-196. PubMed ID: 31985523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage.
    Tsai CT; Liao JN; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chao TF; Lip GYH; Chen SA
    JAMA Netw Open; 2020 Jun; 3(6):e206424. PubMed ID: 32478848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.
    Nielsen PB; Larsen TB; Skjøth F; Gorst-Rasmussen A; Rasmussen LH; Lip GY
    Circulation; 2015 Aug; 132(6):517-25. PubMed ID: 26059010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and Safety of Restarting Oral Anticoagulation in Patients with Atrial Fibrillation after an Intracranial Hemorrhage: Analysis of Medicare Part D Claims Data from 2010-2016.
    Newman TV; Chen N; He M; Saba S; Hernandez I
    Am J Cardiovasc Drugs; 2020 Oct; 20(5):471-479. PubMed ID: 31808136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of the CHA
    Jaakkola S; Kiviniemi TO; Nuotio I; Hartikainen J; Mustonen P; Palomäki A; Jaakkola J; Ylitalo A; Hartikainen P; Airaksinen KEJ
    Am J Cardiol; 2018 May; 121(10):1182-1186. PubMed ID: 29526276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should oral anticoagulants be restarted after warfarin-associated cerebral haemorrhage in patients with atrial fibrillation?
    Paciaroni M; Agnelli G
    Thromb Haemost; 2014 Jan; 111(1):14-8. PubMed ID: 24258528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment strategies for patients with atrial fibrillation and anticoagulant-associated intracranial hemorrhage: an overview of the pharmacotherapy.
    Rivera-Caravaca JM; Esteve-Pastor MA; Camelo-Castillo A; Ramírez-Macías I; Lip GYH; Roldán V; Marín F
    Expert Opin Pharmacother; 2020 Oct; 21(15):1867-1881. PubMed ID: 32658596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of novel oral anticoagulants for patients with atrial fibrillation: systematic review and clinical implications.
    Albert NM
    Heart Lung; 2014; 43(1):48-59. PubMed ID: 24373340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
    Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
    BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalizing Bridging Anticoagulation in Patients with Nonvalvular Atrial Fibrillation-a Microsimulation Analysis.
    Pappas MA; Barnes GD; Vijan S
    J Gen Intern Med; 2017 Apr; 32(4):464-470. PubMed ID: 28120297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation.
    Grosset-Janin D; Barth E; Bertrand B; Detante O
    Rev Neurol (Paris); 2015 May; 171(5):426-32. PubMed ID: 25912470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atrial fibrillation and stroke].
    Mattle HP; Schwerzmann M; Seiler Ch
    Ther Umsch; 2003 Sep; 60(9):527-34. PubMed ID: 14579621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioembolic Stroke Risk and Recovery After Anticoagulation-Related Intracerebral Hemorrhage.
    Murphy MP; Kuramatsu JB; Leasure A; Falcone GJ; Kamel H; Sansing LH; Kourkoulis C; Schwab K; Elm JJ; Gurol ME; Tran H; Greenberg SM; Viswanathan A; Anderson CD; Schwab S; Rosand J; Shi FD; Kittner SJ; Testai FD; Woo D; Langefeld CD; James ML; Koch S; Huttner HB; Biffi A; Sheth KN
    Stroke; 2018 Nov; 49(11):2652-2658. PubMed ID: 30355194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Underuse of oral anticoagulants in atrial fibrillation: a systematic review.
    Ogilvie IM; Newton N; Welner SA; Cowell W; Lip GY
    Am J Med; 2010 Jul; 123(7):638-645.e4. PubMed ID: 20609686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation.
    Di Lullo L; Ronco C; Cozzolino M; Russo D; Russo L; Di Iorio B; De Pascalis A; Barbera V; Galliani M; Vitaliano E; Campana C; Santoboni F; Bellasi A
    Thromb Res; 2017 Jul; 155():38-47. PubMed ID: 28482261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Balancing the risk of stroke and bleeding in atrial fibrillation patients with a history of falls.
    Latt NKZ; Calvert P; Lip GYH
    Expert Opin Drug Saf; 2023; 22(11):1041-1048. PubMed ID: 37860853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of Anticoagulation Resumption and Risk of Ischemic and Hemorrhagic Complications in Patients With ICH and Mechanical Heart Valves.
    Sakusic A; Rabinstein AA; Anisetti B; Mandrekar J; Wijdicks EFM; Freeman WD; Braksick SA
    Neurology; 2024 Aug; 103(4):e209664. PubMed ID: 39102615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.